TG Therapeutics Inc (NASDAQ:TGTX)
| 24.00 Delayed Data As of Nov 26 |  -1.41 / -5.55%Today’s Change | 21.06 Today|||52-Week Range 56.74 | -53.86% Year-to-Date |
Latest TGTX News | Press Releases
| Why TG Therapeutics Is Crashing Today Nov 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 25.41 |
| Today’s open | 25.37 |
| Day’s range | 23.72 - 25.59 |
| Volume | 23,560 |
| Average volume (3 months) | 1,412,631 |
| Market cap | $3.5B |
Data as of 1:00pm ET, 11/26/2021
Growth & Valuation
| Earnings growth (last year) | -23.83% |
| Earnings growth (this year) | -5.84% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 39,471.40 |
| Price/Book | 6.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | -1.63 | -5.33% |
| ITCIIntra-Cellular Thera... | -1.13 | -2.59% |
| ARNAArena Pharmaceutical... | -1.52 | -2.58% |
| ---- |
Data as of 1:00pm ET, 11/26/2021
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | -$0.63 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$279.4M |
| Net profit margin | -183,803.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
